Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Clin Transl Radiat Oncol
; 40: 100613, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-36968576
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Diagnostic_studies
Aspects:
Patient_preference
Language:
En
Journal:
Clin Transl Radiat Oncol
Year:
2023
Document type:
Article
Affiliation country: